Your cart is empty
DAAs decrease hep C deaths but double GPs needed
Hepatitis C deaths have declined by 20% in the two years since direct-acting antivirals were added to the PBS, infectious diseases physicians say. Professor Greg Dore, from the Kirby Institute, says the decline in deaths among patients with liver disease is remarkable and testament to the high uptake of the drugs.
“Around 10% of GPs have written a script for these new therapies — we’d like to potentially double that.”
www.pharmacynews.com.au/news/remarkable-results-daas-decrease-hep-c-deaths
